Clinical Trial Update: Empagliflozin Reversal of Arterial StiffnEss in Aging [Phase 2, Phase 3]

View source ↗

Summary

This document reports that a clinical trial is evaluating empagliflozin for reversing arterial stiffness in aging. The study is currently in Phase 2/Phase 3 and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Stiffness

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Aging, Arterial Stiffness | Phase 2, Phase 3 | Status: RECRUITING